NGAL has been reported to be a useful marker for renal ischemic injury such as that occurring after cardiac surgery [12], [13] and liver transplantation [14], [15], and for acute tubular injury such as cisplatin-induced AKI [35] and contrast-induced nephropathy [36]. Here, LCN2 is linked to acute kidney injury.